191 related articles for article (PubMed ID: 31917039)
1. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
3. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK
Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976
[TBL] [Abstract][Full Text] [Related]
4. One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
Baandrup L; Dehlendorff C; Kjaer SK
Clin Infect Dis; 2021 Nov; 73(9):e3220-e3226. PubMed ID: 33048118
[TBL] [Abstract][Full Text] [Related]
5. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
Dillner J; Nygård M; Munk C; Hortlund M; Hansen BT; Lagheden C; Liaw KL; Kjaer SK
Vaccine; 2018 Jun; 36(26):3820-3829. PubMed ID: 29778519
[TBL] [Abstract][Full Text] [Related]
6. Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.
Nygård S; Nygård M; Orumaa M; Hansen BT
Vaccine; 2023 Aug; 41(37):5469-5476. PubMed ID: 37516572
[TBL] [Abstract][Full Text] [Related]
7. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.
Blomberg M; Dehlendorff C; Munk C; Kjaer SK
Clin Infect Dis; 2013 Oct; 57(7):929-34. PubMed ID: 23804192
[TBL] [Abstract][Full Text] [Related]
8. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.
Blomberg M; Dehlendorff C; Sand C; Kjaer SK
Clin Infect Dis; 2015 Sep; 61(5):676-82. PubMed ID: 25944340
[TBL] [Abstract][Full Text] [Related]
9. Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years into the Danish Human Papillomavirus Vaccination Program for Girls and Women.
Bollerup S; Baldur-Felskov B; Blomberg M; Baandrup L; Dehlendorff C; Kjaer SK
Sex Transm Dis; 2016 Apr; 43(4):238-42. PubMed ID: 26967300
[TBL] [Abstract][Full Text] [Related]
10. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review.
Mariani L; Vici P; Suligoi B; Checcucci-Lisi G; Drury R
Adv Ther; 2015 Jan; 32(1):10-30. PubMed ID: 25620536
[TBL] [Abstract][Full Text] [Related]
11. Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.
Lamb F; Herweijer E; Ploner A; Uhnoo I; Sundström K; Sparén P; Arnheim-Dahlström L
BMJ Open; 2017 Jun; 7(6):e015021. PubMed ID: 28600369
[TBL] [Abstract][Full Text] [Related]
12. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
13. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
14. Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
Righolt CH; Willows K; Kliewer EV; Mahmud SM
PLoS One; 2022; 17(4):e0267646. PubMed ID: 35472093
[TBL] [Abstract][Full Text] [Related]
15. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts.
Smith LM; Strumpf EC; Kaufman JS; Lofters A; Schwandt M; Lévesque LE
Pediatrics; 2015 May; 135(5):e1131-40. PubMed ID: 25917991
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
Fernandes C; Alves J; Rodrigues A; Azevedo J;
Vaccine; 2022 Jan; 40(2):275-281. PubMed ID: 34953608
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266
[TBL] [Abstract][Full Text] [Related]
18. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.
Petry KU; Bollaerts K; Bonanni P; Stanley M; Drury R; Joura E; Kjaer SK; Meijer CJLM; Riethmuller D; Soubeyrand B; Van Damme P; Bosch X
Hum Vaccin Immunother; 2018 Jul; 14(7):1800-1806. PubMed ID: 29553886
[TBL] [Abstract][Full Text] [Related]
20. Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.
Willows K; Bozat-Emre S; Righolt CH; Kliewer EV; Mahmud SM
Sex Transm Dis; 2018 Apr; 45(4):254-259. PubMed ID: 29465699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]